Non-disclosure of drug injection practices as a barrier to HCV testing: results from the PrebupIV community-based research study

• Κύριοι συγγραφείς: Ilhame Anwar (Συγγραφέας), Cécile Donadille (Συγγραφέας), Camelia Protopopescu (Συγγραφέας), David Michels (Συγγραφέας), Joris Herin (Συγγραφέας), Adélaïde Pladys (Συγγραφέας), Danièle Bader (Συγγραφέας), Patrizia Carrieri (Συγγραφέας), Perrine Roux (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: BMC, 2023-07-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Abstract Background Hepatitis C virus (HCV) infection prevalence is particularly high in people who inject drugs (PWID), a population that faces many barriers to HCV testing and care. A better understanding of the determinants of access to HCV testing is needed to improve their engagement in the HCV...